SFI
KRRO icon

Susquehanna Fundamental Investments’s Korro Bio KRRO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$67K Sell
633
-252
-28% -$48.1K ﹤0.01% 1478
2021
Q4 		$227K Sell
885
-50
-5% -$15.2K 0.01% 1198
2021
Q3 		$330K Buy
+935
New +$368K 0.01% 1373

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Susquehanna Fundamental Investments's KRRO Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Korro Bio (KRRO) stake by 28% in Q1 2022, selling an estimated $48.1K and leaving 633 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Susquehanna Fundamental Investments first reported a position in KRRO in Q3 2021 and has held it in 3 quarters since. The position peaked at $330K in Q3 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Susquehanna Fundamental Investments held 633 shares of Korro Bio worth $67K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 252 Korro Bio shares in Q1 2022, an estimated $48.1K.
  • Korro Bio made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1478 holding.
  • Susquehanna Fundamental Investments first reported a position in Korro Bio in Q3 2021 and has held it in 3 quarters since.
  • Susquehanna Fundamental Investments's Korro Bio position peaked at $330K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.